Abstract
Sumatriptan (SUM) is a member of the triptan family that is widely applied for the treatment of cluster headache attacks and migraines. Herein, novel disposable screen-printed sensors (SPS) were incorporated in situ with copper oxide nanoparticles (CuO) and utilized for differential pulse voltammetric determination of the submicromolar concentration of sumatriptan in pharmaceutical formulations and biological fluids. Modification with copper oxide nanoparticles enhanced both the peak height and electroactive surface area which in turn improved the sensitivity towards SUM compared with the blank electrode. At the optimum measuring parameters, the peak heights were linearly proportional to the SUM concentration ranged from 0.33 to 3.54 mu mol L-1 (I-P=0.067+0.132 SUM [mu mol L-1], r=0.9996) with a detection limit (3.3 s/S) 0.066 mu mol L-1. The fabricated sensor showed high sensitivity, fabrication reproducibility and prolonged operational lifetime. The CuO/SPE exhibits improved resolution effect between the sumatriptan voltammetric peaks and those for uric acid, ascorbic acid and paracetamol offering a simple simultaneous determination of sumatriptan in the clinical and pharmaceutical formulations in presence interferents. The applicability of the fabricated modified electrodes was demonstrated by assaying of sumatriptan with sensitivity and selectivity in agreement with the pharmacopial methods. The oxidation of sumatriptan on the electrode surface was studied electrometrically and the proposed mechanism was illustrated with the aid of molecular orbital calculations.